Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: Association of meq mutations with MDVs of high virulence

Veterinary Microbiology

Volumn 102, Issue 3-4, 2004, Pages 147-167

  Shamblin, Christine E ^a   Greene, Natalie ^a   Arumugaswami, Vaithilingaraja ^a   Dienglewicz, Robert L ^a   Parcells, Mark S ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Herpesvirus evolution; Herpesvirus glycoproteins; Marek's disease; Marek's disease virus; Meq oncoprotein

Indexed keywords

PHOSPHOPROTEIN; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; COMPARATIVE STUDY; CORRELATION ANALYSIS; EMBRYO; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRULENCE; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; CELL LINE; CELL LINE, TRANSFORMED; DNA, VIRAL; IMMUNOPHENOTYPING; MARDIVIRUS; MAREK DISEASE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PHOSPHOPROTEINS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POULTRY; VIRAL ENVELOPE PROTEINS; VIRULENCE;

GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE; MAREK'S DISEASE VIRUS SEROTYPE 2 MDV2; MELEAGRID HERPESVIRUS 1;

EID: 4344718864     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2004.06.007     Document Type: Article

References (87)

1. Akiyama Y., Kato S. Two cell lines from lymphomas of Marek's disease. Biken J. 17(3):1974;105-116
2. Baigent S.J., Ross L.J., Davison T.F. Differential susceptibility to Marek's disease is associated with differences in number, but not phenotype or location, of pp38+ lymphocytes. J. Genet. Virol. 79(Pt 11):1998;2795-2802
3. Barrow A., Venugopal K. Molecular characteristics of very virulent European MDV isolates. Acta Virol. 43(2/3):1999;90-93
4. Beasley J.N., Patterson L.T., McWade D.H. Transmission of Marek's disease by poultry house dust and chicken dander. Avian Dis. 14(1):1970;45-53
5. Brunovskis P., Velicer L.F. The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology. 206(1):1995;324-338
6. Calnek, B.W., Witter, R.L., 1997. Marek's disease. In: Calnek, B.W. (Ed.), Diseases of Poultry, 10th ed. Iowa State University Press, Ames, IA, pp. 367-413.
7. Calnek B.W., Adldinger H.K., Kahn D.E. Feather follicle epithelium: a source of enveloped and infectious cell- free herpesvirus from Marek's disease. Avian Dis. 14(2):1970;255-267
8. Calnek B.W., Schat K.A., Ross L.J., Shek W.R., Chen C.L. Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection. Int. J. Cancer. 33(3):1984;389-398
9. Calnek B.W., Harris R.W., Buscaglia C., Schat K.A., Lucio B. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates. Avian Dis. 42(1):1998;124-132
10. Cantello J.L., Anderson A.S., Francesconi A., Morgan R.W. Isolation of a Marek's disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene. J. Virol. 65(3):1991;1584-1588
11. Chan H.M., Smith L., La Thangue N.B. Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein. Oncogene. 20(43):2001;6152-6163
12. Chang Y.E., Poon A.P., Roizman B. Properties of the protein encoded by the UL32 open reading frame of herpes simplex virus 1. J. Virol. 70(6):1996;3938-3946
13. Chang K.S., Lee S.I., Ohashi K., Ibrahim A., Onuma M. The detection of the meq gene in chicken infected with Marek's disease virus serotype 1. J. Vet. Med. Sci. 64(5):2002;413-417
14. Chang K.S., Ohashi K., Onuma M. Diversity (polymorphism) of the meq gene in the attenuated Marek's disease virus (MDV) serotype 1 and MDV-transformed cell lines. J. Vet. Med. Sci. 64(12):2002;1097-1101
15. Chang K.S., Ohashi K., Onuma M. Suppression of transcription activity of the MEQ protein of oncogenic Marek's disease virus serotype 1 (MDV-1) by L-MEQ of non-oncogenic MDV-1. J. Vet. Med. Sci. 64(12):2002;1091-1095
16. Chen X.B., Sondermeijer P.J., Velicer L.F. Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells. J. Virol. 66(1):1992;85-94
17. Churchill A.E., Biggs P.M. Agent of Marek's disease in tissue culture. Res. Vet. Sci. 8(4):1967;440-449
18. Churchill A.E., Chubb R.C., Baxendale W. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J. Genet. Virol. 4(4):1969;557-564
19. Churchill A.E., Payne L.N., Chubb R.C. Marek's disease immunization against Marek's disease using a live attenuated virus. Lancet. 1(7595):1969;610-611
20. Cloud S.S., Lillehoj H.S., Rosenberger J.K. Immune dysfunction following infection with chicken anemia agent and infectious bursal disease virus. I. Kinetic alterations of avian lymphocyte subpopulations. Vet. Immunol. Immunopathol. 34(3/4):1992;337-352
21. Cui Z.Z., Yan D., Lee L.F. Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins. Virus Genes. 3(4):1990;309-322
22. Cui Z.Z., Lee L.F., Liu J.L., Kung H.J. Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J. Virol. 65(1/2):1991;6509-6515
23. Cui Z., Qin A., Lee L.F., Wu P., Kung H.J. Construction and characterization of a H19 epitope point mutant of MDV CVI988/Rispens strain. Acta Virol. 43(2/3):1999;169-173
24. Fan S., Yuan R., Ma Y.X., Xiong J., Meng Q., Erdos M., Zhao J.N., Goldberg I.D., Pestell R.G., Rosen E.M. Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding. Oncogene. 20(35):2001;4827-4841
25. Flamand A., Bennardo T., Babic N., Klupp B.G., Mettenleiter T.C. The absence of glycoprotein gL, but not gC or gK, severely impairs pseudorabies virus neuroinvasiveness. J. Virol. 75(22):2001;11137-11145
26. Gimeno I.M., Witter R.L., Reed W.M. Four distinct neurologic syndromes in Marek's disease: effect of viral strain and pathotype. Avian Dis. 43(4):1999;721-737
27. Ikuta K., Nakajima K., Naito M., Ann S.H., Ueda S., Kato S., Hirai K. Identification of Marek's disease virus-specific antigens in Marek's disease lymphoblastoid cell lines using monoclonal antibody against virus-specific phosphorylated polypeptides. Int. J. Cancer. 35(2):1985;257-264
28. Jones, D., Lee, L., Liu, J.L., Kung, H.J., Tillotson, J.K., 1992. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors [published erratum appears in Proc Natl Acad Sci U.S.A. 90 (6) (1993) 2556]. Proc. Natl. Acad. Sci. U.S.A. 89 (9), 4042-4046.
29. Jones D., Brunovskis P., Witter R., Kung H.J. Retroviral insertional activation in a herpesvirus: transcriptional activation of US genes by an integrated long terminal repeat in a Marek's disease virus clone. J. Virol. 70(4):1996;2460-2467
30. Kung H.J., Xia L., Brunovskis P., Li D., Liu J.L., Lee L.F. Meq: an MDV-specific bZIP transactivator with transforming properties. Curr. Top. Microbiol. Immunol. 255:2001;245-260
31. Lamberti C., Weller S.K. The herpes simplex virus type 1 cleavage/packaging protein, UL32, is involved in efficient localization of capsids to replication compartments. J. Virol. 72(3):1998;2463-2473
32. Lee L.F., Liu X., Witter R.L. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. J. Immunol. 130(2):1983;1003-1006
33. Lee L.F., Wu P., Sui D., Ren D., Kamil J., Kung H.J., Witter R.L. The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc. Natl. Acad. Sci. U.S.A. 97(11):2000;6091-6096
34. Lee S.I., Takagi M., Ohashi K., Sugimoto C., Onuma M. Difference in the meq gene between oncogenic and attenuated strains of Marek's disease virus serotype 1. J. Vet. Med. Sci. 62(3):2000;287-292
35. Li D., Green P.F., Skinner M.A., Jiang C., Ross N. Use of recombinant pp38 antigen of Marek's disease virus to identify serotype 1-specific antibodies in chicken sera by western blotting. J. Virol. Meth. 50(1/3):1994;185-195
36. Lin S.F., Robinson D.R., Miller G., Kung H.J. Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J. Virol. 73(3):1999;1909-1917
37. Liu J.L., Kung H.J. Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style. Virus Genes. 21(12):2000;51-64. (in process citation)
38. Liu J.L., Lee L.F., Ye Y., Qian Z., Kung H.J. Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ. J. Virol. 71(4):1997;3188-3196
39. Liu J.L., Ye Y., Lee L.F., Kung H.J. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis. J. Virol. 72(1):1998;388-395
40. Liu J.L., Ye Y., Qian Z., Qian Y., Templeton D.J., Lee L.F., Kung H.J. Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2. J. Virol. 73(5):1999;4208-4219
41. Lubinski J., Nagashunmugam T., Friedman H.M. Viral interference with antibody and complement. Semin. Cell Dev. Biol. 9(3):1998;329-337
42. Markowski-Grimsrud C.J., Schat K.A. Cytotoxic T lymphocyte responses to Marek's disease herpesvirus-encoded glycoproteins. Vet. Immunol. Immunopathol. 90(3/4):2002;133-144
43. Miles A.M., Anderson A.S., Bernberg E.L., Kent J., Rosenberger J.K., Pope C.R., Morgan R.W. Comparison of two serotype 1 MDV isolates. Acta Virol. 43(2/3):1999;102-105
44. Miles A.M., Reddy S.M., Morgan R.W. Coinfection of specific-pathogen-free chickens with Marek's disease virus (MDV) and chicken infectious anemia virus: effect of MDV pathotype. Avian Dis. 45(1):2001;9-18
45. Morgan R.W., Cantello J.L., McDermott C.H. Transfection of chicken embryo fibroblasts with Marek's disease virus DNA. Avian Dis. 34(2):1990;345-351
46. Novotny M.J., Parish M.L., Spear P.G. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity. Virology. 221(1):1996;1-13
47. Olmeda-Miro, N., Rosenberger, J.K., Cloud, S.S., Pope, C.R., 1996. In vivo characterization of very virulent Marek's disease virus isolates. Paper Presented at the 68th Northeastern Conference on Avian Diseases, The Pennsylvania State University, 10-12 June 1996.
48. Omar A.R., Schat K.A. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology. 222(1):1996;87-99
49. Omar A.R., Schat K.A. Characterization of Marek's disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV. Immunology. 90(4):1997;579-585
50. Omar A.R., Schat K.A., Lee L.F., Hunt H.D. Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek's disease herpesvirus glycoprotein B. Vet. Immunol. Immunopathol. 62(1):1998;73-82
51. Parcells M.S., Anderson A.S., Morgan T.W. Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes. J. Virol. 69(12):1995;7888-7898
52. Parcells M.S., Dienglewicz R.L., Anderson A.S., Morgan R.W. Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome. J. Virol. 73(2):1999;1362-1373
53. Parcells M.S., Arumugaswami V., Prigge J.T., Pandya K., Dienglewicz R.L. Marek's disease virus reactivation from latency: changes in gene expression at the origin of replication. Poult. Sci. 82(6):2003;893-898
54. Petherbridge L., Howes K., Baigent S.J., Sacco M.A., Evans S., Osterrieder N., Nair V. Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J. Virol. 77(16):2003;8712-8718
55. Pratt W.D., Morgan R.W., Schat K.A. Characterization of reticuloendotheliosis virus-transformed avian T-lymphoblastoid cell lines infected with Marek's disease virus. J. Virol. 66(12):1992;7239-7244
56. Qian Z., Brunovskis P., Rauscher F., Lee L., Kung H.J. Transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells. J. Virol. 69(7):1995;4037-4044
57. Qian Z., Brunovskis P., Lee L., Vogt P.K., Kung H.J. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J. Virol. 70(10):1996;7161-7170
58. Rajcani J., Vojvodova A. The role of herpes simplex virus glycoproteins in the virus replication cycle. Acta Virol. 42(2):1998;103-118
59. Rath N.C., Parcells M.S., Xie H., Santin E. Characterization of a spontaneously transformed chicken mononuclear cell line. Vet. Immunol. Immunopathol. 96(1/2):2003;93-104
60. Reddy S.M., Lupiani B., Gimeno I.M., Silva R.F., Lee L.F., Witter R.L. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc. Natl. Acad. Sci. U.S.A. 99(10):2002;7054-7059
61. Rispens B.H., Vloten H.V., Mastenbroek N., Maas H.J., Schat K.A. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 16(1):1972;11-19
62. Rispens B.H., Vloten H.V., Mastenbroek N., Maas J.L., Schat K.A. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 16(1):1972;139-152
63. Robillard N., Jego G., Pellat-Deceunynck C., Pineau D., Puthier D., Mellerin M.P., Barille S., Rapp M.J., Harousseau J.L., Amiot M., Bataille R. CD28, a marker associated with tumoral expansion in multiple myeloma. Clin. Cancer Res. 4(6):1998;1521-1526
64. Rosenberger, J.K., Cloud, S.S., Olmeda-Miro, N., 1997. Epizootiology and adult transmission of Marek's disease. Paper Presented at the Avian Tumor Virus Symposium, Reno, NV, 21 July 1997.
65. Ross N., O'Sullivan G., Rothwell C., Smith G., Burgess S.C., Rennie M., Lee L.F., Davison T.F. Marek's disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas. J. Genet. Virol. 78(9):1997;2191-2198
66. Schat K.A., Calnek B.W. Characterization of an apparently non-oncogenic Marek's disease virus. J. Natl. Cancer Inst. 60(5):1978;1141-1146
67. Schat K.A., Calnek B.W., Fabricant J. Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 11:1982;593-605
68. Schat K.A., Chen C.L., Shek W.R., Calnek B.W. Surface antigens on Marek's disease lymphoblastoid tumor cell lines. J. Natl. Cancer Inst. 69(3):1982;715-720
69. Schat K.A., Chen C.L., Calnek B.W., Char D. Transformation of T-lymphocyte subsets by Marek's disease herpesvirus. J. Virol. 65(3):1991;1408-1413
70. Schumacher D., Tischer B.K., Fuchs W., Osterrieder N. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 74(23):2000;11088-11098
71. Schumacher D., Tischer B.K., Reddy S.M., Osterrieder N. Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J. Virol. 75(23):2001;11307-11318
72. Scott S.D., Smith G.D., Ross N.L., Binns M.M. Identification and sequence analysis of the homologues of the herpes simplex virus type 1 glycoprotein H in Marek's disease virus and the herpesvirus of turkeys. J. Genet. Virol. 74(Pt 6):1993;1185-1190
73. Shek W.R., Calnek B.W., Schat K.A., Chen C.H. Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. J. Natl. Cancer Inst. 70(3):1983;485-491
74. Silva R.F., Lee L.F. Monoclonal antibody-mediated immunoprecipitation of proteins from cells infected with Marek's disease virus or turkey herpesvirus. Virology. 136(2):1984;307-320
75. Solomon J.J., Witter R.L., Nazerian K., Burmester B.R. Studies on the etiology of Marek's disease. I. Propagation of the agent in cell culture. Proc. Soc. Exp. Biol. Med. 127(1):1968;173-177
76. Tischer B.K., Schumacher D., Messerle M., Wagner M., Osterrieder N. The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J. Genet. Virol. 83(Pt 5):2002;997-1003
77. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Rock D.L., Kutish G.F. The genome of a very virulent Marek's disease virus. J. Virol. 74(17):2000;7980-7988
78. Witter R.L. Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency. Avian Dis. 27(1):1983;113-132
79. Witter R.L. Avian tumor viruses: persistent and evolving pathogens. Acta Vet. Hung. 45(3):1997;251-266
80. Witter R.L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41(1):1997;149-163
81. Witter R.L., Burgoyne G.H., Solomon J.J. Evidence for a herpesvirus as an etiologic agent of Marek's disease. Avian Dis. 13(1):1969;211-214
82. Witter R.L., Nazerian K., Purchase H.G., Burgoyne G.H. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Biken J. 13(1):1970;53-57
83. Wu P., Lee L.F., Reed W.M. Serological characteristics of a membrane glycoprotein gp82 of Marek's disease virus. Avian Dis. 41(4):1997;824-831
84. Yamasaki L. Role of the RB tumor suppressor in cancer. Cancer Treat. Res. 115:2003;209-239
85. Yanagida N., Ogawa R., Li Y., Lee L.F., Nazerian K. Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek's disease virus. J. Virol. 66(3):1992;1402-1408
86. Yoshida S., Lee L.F., Yanagida N., Nazerian K. Identification and characterization of a Marek's disease virus gene homologous to glycoprotein L of herpes simplex virus. Virology. 204(1):1994;414-419
87. Zhang X.G., Olive D., Devos J., Rebouissou C., Ghiotto-Ragueneau M., Ferlin M., Klein B. Malignant plasma cell lines express a functional CD28 molecule. Leukemia. 12(4):1998;610-618